The Future of Patient-Centric Access is Here!

The 6th Annual Operationalize: Expanded Access Programs Summit returns to Boston in 2026 as the premier forum for access, medical affairs, clinical operations, and supply-chain professionals working to turn patient need into accessible therapies. This event brings together 140+ global experts dedicated to designing, scaling, and optimising expanded access and early-access programmes in rare disease, oncology, advanced therapies, and emerging markets.

In a landscape where access is no longer an after-thought, but a strategic imperative, this summit tackles the full lifecycle of programmes: from first request, through real-world-data capture, to exit strategies and commercial transition. Expect cutting-edge content on global regulatory harmonisation, supply and logistics in low- and middle-income countries, and smart use of AI and digital tools to forecast demand and streamline programme operations.

What You’ll Gain

Master how to launch and scale Expanded Access Programmes (EAPs) internationally, aligning strategy, operations, and supply.
Unlock real-world evidence (RWD) strategies that support regulatory and commercial outcomes without compromising ethics or compliance.
Build operational resilience across multi-geography supply chains, including in challenging regions, leveraging AI and digital forecasting tools.
Engage in actionable workshops and peer-case studies covering programme exit, post-trial access, paid-for and free-of-charge models.

Visionary Faculty Includes

Speakers from leading organisations, including:

AstraZeneca - global access leads tackling regional complexity
Regeneron Pharmaceuticals - experts turning compassionate-use data into regulatory impact
Savara Pharmaceuticals - leadership in patient engagement and medical affairs
The Max Foundation - operators of global access initiatives in emerging markets

Why Attend?

Three full days of immersive learning, spanning discovery, access strategy, and execution
25+ expert speakers presenting real-world case studies and actionable frameworks
8+ hours of structured networking, connecting with access-leaders, service-providers, and regulators
Dedicated tracks for scaling EAPs, integrating RWD, and managing supply for gene and rare-disease therapies
The industry’s most focused meeting for professionals orchestrating global patient access programmes

Don’t miss the only dedicated summit that brings together the full ecosystem of expanded access, from biotech innovators through to supply-chain operators and regulatory strategists. Join us in Boston and help drive meaningful patient impact through access that’s compliant, scalabl,e and patient-centric.

Register your place today: https://ter.li/jqkfv0